Found: 3
Select item for more details and to access through your institution.
The role of polo‐like kinase 3 in the response of BRAF‐mutant cells to targeted anticancer therapies.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 1, p. 5, doi. 10.1002/mc.23123
- By:
- Publication type:
- Article
Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo.
- Published in:
- Biomedicines, 2023, v. 11, n. 1, p. 230, doi. 10.3390/biomedicines11010230
- By:
- Publication type:
- Article
PAK1 and Therapy Resistance in Melanoma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 19, p. 2373, doi. 10.3390/cells12192373
- By:
- Publication type:
- Article